Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for prevention of renal ischemic injury during partial nephrectomy
MOH_2018-07-18_003525Phase 2Not yet recruiting
- Sponsor
- עפר נתיב
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of spironolactone in acute kidney failure (AKF) and Kidney ischemia reperfusion injury (2 arms), sponsored by עפר נתיב. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
spironolactone
03
Conditions
acute kidney failure (AKF)Kidney ischemia reperfusion injury
Beyond the preview
Go deeper on MOH_2018-07-18_003525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-07-18_003525.